<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37920139</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2056-4724</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>03</Day></PubDate></JournalIssue><Title>BJPsych open</Title><ISOAbbreviation>BJPsych Open</ISOAbbreviation></Journal><ArticleTitle>Psychological risk factors for Long COVID and their modification: study protocol of a three-arm, randomised controlled trial (SOMA.COV).</ArticleTitle><Pagination><StartPage>e207</StartPage><MedlinePgn>e207</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e207</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1192/bjo.2023.591</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Growing evidence suggests that in addition to pathophysiological, there are psychological risk factors involved in the development of Long COVID. Illness-related anxiety and dysfunctional symptom expectations seem to contribute to symptom persistence.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">With regard to the development of effective therapies, our primary aim is to investigate whether symptoms of Long COVID can be improved by a targeted modification of illness-related anxiety and dysfunctional symptom expectations. Second, we aim to identify additional psychosocial risk factors that contribute to the persistence of Long COVID, and compare them with risk factors for symptom persistence in other clinical conditions.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We will conduct an observer-blinded, three-arm, randomised controlled trial. A total of 258 patients with Long COVID will be randomised into three groups of equal size: targeted expectation management in addition to treatment as usual (TAU), non-specific supportive treatment plus TAU, or TAU only. Both active intervention groups will comprise three individual online video consultation sessions and a booster session after 3 months. The primary outcome is baseline to post-interventional change in overall somatic symptom severity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study will shed light onto the action mechanisms of a targeted expectation management intervention for Long COVID, which, if proven effective, can be used stand-alone or in the context of broader therapeutic approaches. Further, the study will enable a better understanding of symptom persistence in Long COVID by identifying additional psychological risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Engelmann</LastName><ForeName>Petra</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9654-0364</Identifier><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;chel</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frommhold</LastName><ForeName>J&#xf6;rdis</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute Long Covid, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klose</LastName><ForeName>Hans F E</ForeName><Initials>HFE</Initials><AffiliationInfo><Affiliation>II. Medical Clinic and Polyclinic, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lohse</LastName><ForeName>Ansgar W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maehder</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nestoriuc</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany; and Department of Psychology, Helmut Schmidt University, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suling</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toussaint</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weigel</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zapf</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;we</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4220-3378</Identifier><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>508447247</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJPsych Open</MedlineTA><NlmUniqueID>101667931</NlmUniqueID><ISSNLinking>2056-4724</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">biopsychosocial model</Keyword><Keyword MajorTopicYN="N">persistent somatic symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>3</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37920139</ArticleId><ArticleId IdType="pmc">PMC10753953</ArticleId><ArticleId IdType="doi">10.1192/bjo.2023.591</ArticleId><ArticleId IdType="pii">S2056472423005914</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med 2021; 27(4): 626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8(5): 416&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry 2022; 79(11): 1081&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann P, Toussaint A, Addo MM, Brehm TT, Lohse AW, Weigel A, et al. Predictors of somatic symptom burden in healthcare professionals during the COVID-19 pandemic: an 8-week follow-up study. J Ment Health [Epub ahead of print] 13 May 2022. Available from: 10.1080/09638237.2022.2069709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638237.2022.2069709</ArticleId><ArticleId IdType="pubmed">35549625</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann P, L&#xf6;we B, Brehm TT, Weigel A, Ullrich F, Addo MM, et al. Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic. Front Psychol 2022; 13: 1022203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9631939</ArticleId><ArticleId IdType="pubmed">36337508</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med 2022; 182(1): 19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE, 2021.  (www.nice.org.uk/guidance/ng188).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, et al. S1-Leitlinie Post-COVID/Long-COVID [S1 Guideline Post-COVID/Long-COVID]. Pneumologie 2021; 75(11): 869&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Andresen V, Van den Bergh O, Huber TB, von dem Knesebeck O, Lohse AW, et al. Persistent somatic symptoms across diseases &#x2013; from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211). BMJ Open 2022; 12(1): e057596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785206</ArticleId><ArticleId IdType="pubmed">35063961</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Update 54 &#x2013; Clinical Long-Term Effects of COVID-19. WHO, 2021.  (https://www.who.int/publications/m/item/update-54-clinical-long-term-effects-of-covid-19).</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11: 16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis 2022; 74(7): 1191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Henningsen P, Zipfel S, Sattel H, Creed F. Management of functional somatic syndromes and bodily distress. Psychother Psychosom 2018; 87(1): 12&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">29306954</ArticleId></ArticleIdList></Reference><Reference><Citation>Monden R, Rosmalen JG, Wardenaar KJ, Creed F. Predictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study. Psychol Med 2022; 52(1): 112&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8711101</ArticleId><ArticleId IdType="pubmed">32546287</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferton JA, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC. Patients&#x2019; expectations regarding medical treatment: a critical review of concepts and their assessment. Front Psychol 2017; 8: 233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318458</ArticleId><ArticleId IdType="pubmed">28270786</ArticleId></ArticleIdList></Reference><Reference><Citation>Rief W, Martin A. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications. Annu Rev Clin Psychol 2014; 10: 339&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">24387234</ArticleId></ArticleIdList></Reference><Reference><Citation>Henningsen P, G&#xfc;ndel H, Kop WJ, L&#xf6;we B, Martin A, Rief W, et al. Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom Med 2018; 80(5): 422&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">29621046</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022; 185(5): 881&#x2013;95.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect 2021; 82(3): 378&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur Heart J 2022; 43(11): 1124&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevlin M, Nolan E, Owczarek M, McBride O, Murphy J, Gibson Miller J, et al. COVID-19-related anxiety predicts somatic symptoms in the UK population. Br J Health Psychol 2020; 25(4): 875&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283836</ArticleId><ArticleId IdType="pubmed">32458550</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss-Morris R, Spence M, Hou R. The pathway from glandular fever to chronic fatigue syndrome: can the cognitive behavioural model provide the map? Psychol Med 2011; 41(5): 1099&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">20663256</ArticleId></ArticleIdList></Reference><Reference><Citation>Vase L, Vollert J, Finnerup NB, Miao X, Atkinson G, Marshall S, et al. Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials. Pain 2015; 156(9): 1795&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955965</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2015; 12(8): 472&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">26194942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64(2): 258&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Meister R, L&#xf6;we B, Kaptchuk TJ, Buhling KJ, Nestoriuc Y. Open-label placebos for menopausal hot flushes: a randomized controlled trial. Sci Rep 2020; 10(1): 20090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674475</ArticleId><ArticleId IdType="pubmed">33208855</ArticleId></ArticleIdList></Reference><Reference><Citation>Rief W, Shedden-Mora MC, Laferton JA, Auer C, Petrie KJ, Salzmann S, et al. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med 2017; 15(1): 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5223324</ArticleId><ArticleId IdType="pubmed">28069021</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Nestoriuc Y, Andresen V, Vettorazzi E, Zapf A, H&#xfc;bener S, et al. Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT). BMJ Open 2022; 12(6): e059529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198710</ArticleId><ArticleId IdType="pubmed">35701050</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzmann S, Laferton JAC, Shedden-Mora MC, Horn N, G&#xe4;rtner L, Schr&#xf6;der L, et al. Pre-surgery optimization of patients&#x2019; expectations to improve outcome in heart surgery: study protocol of the randomized controlled multi-center PSY-HEART-II trial. Am Heart J 2022; 254: 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">35940247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB, L&#xf6;we B. The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010; 32(4): 345&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993; 37(2): 147&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason L. A brief questionnaire to assess post-exertional malaise. Diagnostics 2018; 8(3): 66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait RC, Pollard CA, Margolis RB, Duckro PN, Krause SJ. The Pain Disability Index: psychometric and validity data. Arch Phys Med Rehabil 1987; 68(7): 438&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">3606368</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med 2022; 28(5): 911&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint A, Murray AM, Voigt K, Herzog A, Gierk B, Kroenke K, et al. Development and validation of the Somatic Symptom Disorder&#x2013;B Criteria Scale (SSD-12). Psychosom Med 2016; 78(1): 5&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">26461855</ArticleId></ArticleIdList></Reference><Reference><Citation>Rief W, Burton C, Frostholm L, Henningsen P, Kleinst&#xe4;uber M, Kop WJ, et al. Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: European Network on Somatic Symptom Disorders recommendations. Psychosom Med 2017; 79(9): 1008&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">28691994</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberts J, L&#xf6;we B, Glahn MA, Petrie K, Laferton J, Nestoriuc Y, et al. Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews. BMJ Open 2020; 10(8): e036169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440833</ArticleId><ArticleId IdType="pubmed">32819942</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Blankenberg S, Wegscheider K, K&#xf6;nig HH, Walter D, Murray AM, et al. Depression screening with patient-targeted feedback in cardiology: DEPSCREEN-INFO randomised clinical trial. Br J Psychiatry 2017; 210(2): 132&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27908896</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Hopewell S, Schulz KF, Montori V, G&#xf8;tzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012; 10(1): 28&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">22036893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohlmann S, Lehmann M, Eisele M, Braunschneider L, Marx G, Zapf A, et al. Depression screening using patient-targeted feedback in general practices: study protocol of the German multicentre GET.FEEDBACK.GP randomised controlled trial. BMJ Open 2020; 10(9): e035973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507856</ArticleId><ArticleId IdType="pubmed">32958483</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021; 27(2): 258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>